NEW YORK (GenomeWeb) – FlowJo and Becton Dickinson said today that they have established a strategic relationship in the area of single-cell analysis.

Under the agreement, the companies will market FlowJo Envoy, cloud-based data-analysis software, with BD's FACSymphony, a cell analyzer enabling the simultaneous measurement of up to 50 characteristics of a single cell.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Nuffield Council on Bioethics says genetically modifying human embryos could be morally permissible, according to the Guardian.

A new Nature Biotechnology paper reports that CRISPR-Cas9 gene editing can lead to large deletions or complex rearrangements that could be pathogenic.

The Wall Street Journal likens a prototype developed by Synthetic Genomics to a "biological fax machine."

In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.